| Literature DB >> 32908918 |
Jin Cai1,2,3, Liang Zhou1,2, Xiudao Song1,2, Meiqi Yin1,4, Guoqiang Liang1,2, Heng Xu1,2, Lurong Zhang1,2, Guorong Jiang1,2, Fei Huang1,4.
Abstract
Our previous research suggests that 3-deoxyglucosone (3DG), formed in the caramelization course and Maillard reactions in food, is an independent factor for the development of prediabetes. Since the relationship between type 2 diabetes (T2D) and intestinal microbiota is moving from correlation to causality, we investigated the alterations in the composition and function of the intestinal microbiota in 3DG-induced prediabetic rats. Rats were given 50 mg/kg 3DG by intragastric administration for two weeks. Microbial profiling in faeces samples was determined through the 16S rRNA gene sequence. The glucagon-like peptide 2 (GLP-2) and lipopolysaccharide (LPS) levels in plasma and intestinal tissues were measured by ELISA and Limulus test, respectively. 3DG treatment did not significantly change the richness and evenness but affected the composition of intestinal microbiota. At the phylum level, 3DG treatment increased the abundance of nondominant bacteria Proteobacteria but did not cause the change of the dominant bacteria. Meanwhile, the abundance of the Prevotellaceae family and Parasutterela genus and the Alcaligencaeae family and Burkholderiales order and its attachment to the Betaproteobacteria class were overrepresented in the 3DG group. The bacteria of Candidatus Soleaferrea genus, Gelria genus, and Thermoanaerobacteraceae family and its attachment to Thermoanaerobacterales order were apparently more abundant in the control group. In addition, 45 KEGG pathways were altered after two-week intragastric administration of 3DG. Among these KEGG pathways, 13 KEGG pathways were involved in host metabolic function related to amino acid metabolism, carbohydrate metabolism, metabolism of cofactors and vitamins, and metabolism of terpenoids and polyketides. Moreover, the increased LPS levels and the decreased GLP-2 concentration in plasma and intestinal tissues were observed in 3DG-treated rats, together with the impaired fasting glucose and oral glucose tolerance. The alterations in composition and function of the intestinal microbiota were observed in 3DG-treated rats, which provides a possible mechanism linking exogenous 3DG intake to the development of prediabetes.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32908918 PMCID: PMC7468600 DOI: 10.1155/2020/8406846
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Venn map of OTUs, n = 10 for each group. There were 329 common OTUs in NC and 3DG-treated rats. 17 species were specific to the NC group, and 26 species were specific to the 3DG group.
Figure 2Changes in community diversity of the intestinal microbiota two weeks after intragastric administration of 3DG, n = 10 for each group. ACE (a), Chao (b), Shannon (c), and Simpson (d) indices of α-diversity were compared between NC and 3DG-treated rats. Statistical testing showed no significant difference for ACE, Chao, Shannon, and Simpson indices. β-Diversity analysis including Principal Coordinates Analysis (PCoA) (e) and nonmetric multidimensional scaling (NMDS) (f) performed with Jaccard dissimilarity of the OTU abundance. The contributions of principal coordinate 1 (PC1) is on the x-axis and 2 (PC2) is on the y-axis.
Figure 3Changes in intestinal microbiota at different bacterial taxonomic information two weeks after intragastric administration of 3DG, n = 10 for each group. (a) Pie charts of intestinal microbiota at the phylum level in NC (left) and 3DG-treated (right) rats. (b) Specific difference analysis at the phylum level of the two groups. Proteobacteria was significantly increased in the 3DG group (values are the mean ± SD, ∗p < 0.05). (c) Bar plot of intestinal microbiota differences at the genus level.
Figure 4Specific species altered by two-week intragastric administration of 3DG, n = 10 for each group. (a) Cladogram using the LEfSe method indicated the phylogenetic distribution of faeces microbes associated with NC (green) and 3DG-treated rats (red). (b) LDA scores (>2) showed the biomarkers and significant bacterial difference between NC and 3DG-treated rats. (c) Bar plot of species importance at the genus level performed by random forest analysis. The abscissa is the importance level, and the ordinate is the species name sorted by importance.
Figure 5Predictive analysis in the potential metabolic function of intestinal microbiota by PICRUSt, n = 10 for each group. (a) PCA of KEGG pathway profile between 3DG-treated and NC rats. (b) The potential metabolism function of KEGG pathways of levels 2 and 3 is shown. A p value < 0.05 was considered statistically significant.
Figure 6Increased LPS level and decreased GLP-2 level in plasma and colon of rats 2 weeks after intragastric administration of 3DG, n = 7 for each group. Plasma (a) and colon LPS (C) levels were significantly increased; plasma (b) and colon (d) GLP-2 levels were significantly decreased compared with the NC group. Values are the mean ± SD. ∗p < 0.05, ∗∗p < 0.01. (e) Correlation between colon LPS level and abundance of Parasutterella. (f) Correlation between colon GLP-2 level and abundance of Candidatus Soleaferrea. The inset corresponds to Pearson's r correlation and corresponding p value.
Figure 7Intragastric administration of 3DG for 2 weeks caused normal rats to develop increased fasting blood glucose concentration and impaired oral glucose tolerance. n = 7 for each group. (a) Fasting plasma glucose levels were measured in rats after 2 weeks of 3DG (50 mg/kg) or vehicle treatment. (b) OGTT (2.5 g/kg) was performed after 2-week administration of 3DG (50 mg/kg) or vehicle in rats. (c) The glycaemic response was expressed as the area under the curve. Values are the mean ± SD. ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001 compared with the control group.